What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Gene
Daniel R. Kuritzkes spends much of his time researching Immunology, Virology, Drug resistance, Acquired immunodeficiency syndrome and Internal medicine.
Specifically, his work in Virology is concerned with the study of Zidovudine.
His Drug resistance study combines topics in areas such as Reverse transcriptase, Bioinformatics, Regimen, Genotype and Drug.
His work in Acquired immunodeficiency syndrome addresses subjects such as Intensive care medicine, which are connected to disciplines such as Clinical research.
Daniel R. Kuritzkes has researched Internal medicine in several fields, including Efavirenz, Oncology and Reverse-transcriptase inhibitor.
His Viral load research is multidisciplinary, relying on both Viremia and Antibody.
His most cited work include:
- Update of the Drug Resistance Mutations in HIV-1. (1203 citations)
- The major genetic determinants of HIV-1 control affect HLA class I peptide presentation (910 citations)
- Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. (775 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Immunology, Viral load, Virus and Internal medicine.
The Virology study combines topics in areas such as Mutation, Reverse transcriptase and Drug resistance.
In his research on the topic of Immunology, Clinical trial and Intensive care medicine is strongly related with Acquired immunodeficiency syndrome.
His study focuses on the intersection of Viral load and fields such as Ritonavir with connections in the field of Lopinavir.
His Virus research incorporates themes from RNA and CCR5 receptor antagonist.
The various areas that Daniel R. Kuritzkes examines in his Internal medicine study include Gastroenterology, Efavirenz, Oncology and Reverse-transcriptase inhibitor.
He most often published in these fields:
- Virology (47.25%)
- Immunology (41.95%)
- Viral load (24.15%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (41.95%)
- Viral load (24.15%)
- Virology (47.25%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Viral load, Virology, Antiretroviral therapy and Immune system.
His Immunology research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation, Clinical trial, Acquired immunodeficiency syndrome and Cohort.
The concepts of his Viral load study are interwoven with issues in Viremia, Internal medicine, Lymphocyte, Viral rebound and Viral replication.
Particularly relevant to Lentivirus is his body of work in Virology.
His studies in Antiretroviral therapy integrate themes in fields like MEDLINE and Intensive care medicine.
His Immune system study incorporates themes from Virus, Lymphatic system and Antibody.
Between 2015 and 2021, his most popular works were:
- International AIDS Society global scientific strategy: towards an HIV cure 2016 (268 citations)
- HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study (121 citations)
- HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study (121 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Virus
Daniel R. Kuritzkes mostly deals with Viral load, Immunology, Virology, RNA and Antiretroviral therapy.
His work deals with themes such as Preventive healthcare, Viremia, Integrase inhibitor, Internal medicine and Viral replication, which intersect with Viral load.
His study in Immune system and Virus falls within the category of Immunology.
His Virology research integrates issues from Cell and Motion sensing.
Daniel R. Kuritzkes combines subjects such as Autologous transplantation, Stem cell and Intensive care medicine with his study of Antiretroviral therapy.
His Lamivudine study combines topics from a wide range of disciplines, such as Reverse transcriptase, Drug development and Zidovudine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
